Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Spectrum Pharmaceuticals Q4 EPS $(0.06) Beats $(0.11) Estimate, Sales $10.11M Beat $8.92M Estimate

Author: Benzinga Newsdesk | March 22, 2023 08:03am
Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 64.71 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $10.11 million which beat the analyst consensus estimate of $8.92 million by 13.39 percent.

Posted In: SPPI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist